Bessemer Group Inc Care Dx, Inc. Transaction History

Bessemer Group Inc

$60.7 Billion
Q3 2024

A detailed history of Bessemer Group Inc transactions in Care Dx, Inc. stock. As of the latest transaction made, Bessemer Group Inc holds 45 shares of CDNA stock, worth $963. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Holding current value

$963

% of portfolio

0.0%

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$14.41 - $33.99 $648 - $1,529	45 New	45 $1,000
Q4 2021 Jan 27, 2022	SELL	$41.2 - $73.6 $6,921 - $12,364	-168 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$59.15 - $91.99 $9,937 - $15,454	168 New	168 $11,000

Others Institutions Holding CDNA

# of Institutions

218

Shares Held

51.1M

Call Options Held

97.3K

Put Options Held

43.3K

Black Rock Inc. New York, NY

5.29M
Shares

$113 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

4.54M
Shares

$97.2 Million
0.0% of portfolio
Bellevue Group Ag Kuesnacht, V8

3.15M
Shares

$67.4 Million
1.65% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

2.99M
Shares

$64 Million
0.89% of portfolio
State Street Corp Boston, MA

2.04M
Shares

$43.6 Million
0.0% of portfolio

View Full List

About CareDx, Inc.

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $1.15B
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

More about CDNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.

Account